Table 3.
Age-adjusted prevalence of NAFLD stage by race/ethnicity and gender.
| Variable | Male (n = 1,596) | Female no menopause (N = 1,186) | Female menopause no hormone (N = 400) | Female menopause plus hormone (N = 110) | p-value |
|---|---|---|---|---|---|
| Overall | <0.001 | ||||
| Normal/mild | 745 (48.12) | 689 (57.60) | 179 (45.20) | 55 (23.44) | |
| Moderate | 254 (15.86) | 193 (16.07) | 70 (24.72) | 22 (43.08) | |
| Severe | 597 (36.01) | 304 (26.32) | 151 (30.08) | 33 (33.47) | |
| Mexican American | <0.001 | ||||
| Normal/mild | 62 (26.45) | 80 (46.10) | 12 (57.30) | 3 (49.31) | |
| Moderate | 39 (17.70) | 26 (16.97) | 9 (15.57) | 1 (7.60) | |
| Severe | 111 (55.83) | 67 (36.92) | 25 (27.14) | 6 (43.09) | |
| Other Hispanics | 0.9945 | ||||
| Normal/mild | 66 (56.04) | 53 (58.11) | 21 (54.90) | 7 (49.57) | |
| Moderate | 23 (14.49) | 11 (12.43) | 8 (14.66) | 2 (16.40) | |
| Severe | 51 (29.45) | 27 (29.45) | 12 (30.45) | 5 (34.03) | |
| Blacks | 0.4346 | ||||
| Normal/mild | 208 (60.19) | 164 (60.38) | 41 (60.67) | 11 (40.59) | |
| Moderate | 50 (15.37) | 47 (17.55) | 14 (15.32) | 4 (13.48) | |
| Severe | 90 (24.43) | 53 (22.07) | 34 (24.03) | 2 (45.93) | |
| Whites | <0.001 | ||||
| Normal/mild | 259 (49.02) | 253 (59.36) | 69 (48.28) | 24 (21.46) | |
| Moderate | 90 (14.95) | 68 (15.19) | 24 (16.95) | 12 (47.91) | |
| Severe | 239 (36.01) | 114 (25.45) | 51 (34.77) | 17 (30.62) | |
| Others | 0.0083 | ||||
| Normal/mild | 150 (47.37) | 139 (57.40) | 36 (29.23) | 10 (47.37) | |
| Moderate | 52 (19.73) | 41 (24.59) | 15 (41.49) | 3 (19.89) | |
| Severe | 106 (32.89) | 43 (18.00) | 29 (29.28) | 3 (32.89) |